Extraordinary General Meeting, Tuesday, February 15, 2022
An Extraordinary General Meeting of Orphazyme A/S, CVR no. 32 26 63 55 (the “Company”), will be held on Tuesday, February 15, 2022 at 5:00 PM (CET), at the Company’s address Ole Maaløes Vej 3, DK-2200 Copenhagen N, Denmark.
Shareholders wishing to attend the Extraordinary General Meeting in person are encouraged not to bring advisors or other authorized guests to limit the number of physical attendees at the Extraordinary General Meeting. Further, meeting participants will be asked to present a valid corona passport and meeting participants having or showing symptoms of virus infection are kindly requested not to attend the meeting.
Shareholders who do not attend the Extraordinary General Meeting in person are encouraged to exercise their shareholder rights by giving proxy to the Board of Directors or by voting by correspondence prior to the Extraordinary General Meeting.
At the day of the notice of the Extraordinary General Meeting, the Company’s nominal share capital amounts to DKK 34,952,241 divided into 34,952,241 shares of DKK 1 each. Each share of the nominal value of DKK 1 carries one vote.
Please visit our Investor Portal for further information about the Extraordinary General Meeting.